v3.26.1
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series C-2 Preferred Stock
Series D Preferred Stock
Common Stock
Additional Paid In Capital
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2024 9,608,914          
Balance at the beginning at Dec. 31, 2024 $ 72,546          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Issuance of Series C-2 redeemable convertible preferred stock, net of issuance costs and tranche liability (in shares) 4,933,589          
Issuance of Series C-2 and D redeemable convertible preferred stock, net of issuance costs $ 54,939          
Balance at the end (in shares) at Mar. 31, 2025 14,542,503          
Balance at the end at Mar. 31, 2025 $ 127,485          
Beginning balance (in shares) at Dec. 31, 2024       2,196,423    
Beginning balance at Dec. 31, 2024 (60,474)     $ 0 $ 4,387 $ (64,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)       86,579    
Stock option exercises 100       100  
Stock-based compensation 345       345  
Net loss (8,823)         (8,823)
Comprehensive loss (8,823)         (8,823)
Ending balance (in shares) at Mar. 31, 2025       2,283,002    
Ending balance at Mar. 31, 2025 $ (68,852)     $ 0 4,832 (73,684)
Balance at the beginning (in shares) at Dec. 31, 2024 9,608,914          
Balance at the beginning at Dec. 31, 2024 $ 72,546          
Balance at the end (in shares) at Jun. 30, 2025 20,341,968          
Balance at the end at Jun. 30, 2025 $ 204,537          
Beginning balance (in shares) at Dec. 31, 2024       2,196,423    
Beginning balance at Dec. 31, 2024 (60,474)     $ 0 4,387 (64,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (17,498)          
Comprehensive loss (17,498)          
Ending balance (in shares) at Jun. 30, 2025       2,118,652    
Ending balance at Jun. 30, 2025 $ (78,379)     $ 0 3,980 (82,359)
Balance at the beginning (in shares) at Dec. 31, 2024 9,608,914          
Balance at the beginning at Dec. 31, 2024 $ 72,546          
Balance at the end (in shares) at Dec. 31, 2025 20,341,968          
Balance at the end at Dec. 31, 2025 $ 204,537          
Beginning balance (in shares) at Dec. 31, 2024       2,196,423    
Beginning balance at Dec. 31, 2024 $ (60,474)     $ 0 4,387 (64,861)
Ending balance (in shares) at Dec. 31, 2025 2,203,620     2,203,620    
Ending balance at Dec. 31, 2025 $ (98,837)     $ 0 5,893 (104,730)
Balance at the beginning (in shares) at Mar. 31, 2025 14,542,503          
Balance at the beginning at Mar. 31, 2025 $ 127,485          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Series C-2 redeemable convertible preferred stock issuance costs   $ 7        
Issuance of Series C-2 redeemable convertible preferred stock, net of issuance costs and tranche liability (in shares)     5,799,465      
Issuance of Series C-2 and D redeemable convertible preferred stock, net of issuance costs     $ 77,059      
Balance at the end (in shares) at Jun. 30, 2025 20,341,968          
Balance at the end at Jun. 30, 2025 $ 204,537          
Beginning balance (in shares) at Mar. 31, 2025       2,283,002    
Beginning balance at Mar. 31, 2025 (68,852)     $ 0 4,832 (73,684)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)       10,082    
Stock option exercises 11       11  
Stock-based compensation 587       587  
Repurchase of common stock (in shares)       (174,432)    
Repurchase of common stock (1,450)       (1,450)  
Net loss (8,675)         (8,675)
Comprehensive loss (8,675)         (8,675)
Ending balance (in shares) at Jun. 30, 2025       2,118,652    
Ending balance at Jun. 30, 2025 $ (78,379)     $ 0 3,980 (82,359)
Balance at the beginning (in shares) at Dec. 31, 2025 20,341,968          
Balance at the beginning at Dec. 31, 2025 $ 204,537          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Conversion of redeemable convertible preferred stock into common stock on the initial public offering (in shares) (20,341,968)          
Conversion of redeemable convertible preferred stock into common stock on the initial public offering $ (204,537)          
Balance at the end (in shares) at Mar. 31, 2026 0          
Balance at the end at Mar. 31, 2026 $ 0          
Beginning balance (in shares) at Dec. 31, 2025 2,203,620     2,203,620    
Beginning balance at Dec. 31, 2025 $ (98,837)     $ 0 5,893 (104,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)       105,717    
Stock option exercises 55       55  
Stock-based compensation 1,675       1,675  
Conversion of redeemable convertible preferred stock into common stock on the initial public offering (in shares)       20,341,968    
Conversion of redeemable convertible preferred stock into common stock on the initial public offering 204,537       204,537  
Issuance of common stock in initial public offering, net of underwriting discounts and commissions and offering costs (in shares)       10,781,250    
Issuance of common stock in initial public offering, net of underwriting discounts and commissions and offering costs 156,500       156,500  
Net loss (13,818)         (13,818)
Comprehensive loss (13,818)         (13,818)
Ending balance (in shares) at Mar. 31, 2026       33,432,555    
Ending balance at Mar. 31, 2026 $ 250,112     $ 0 368,660 (118,548)
Balance at the beginning (in shares) at Dec. 31, 2025 20,341,968          
Balance at the beginning at Dec. 31, 2025 $ 204,537          
Balance at the end (in shares) at Jun. 30, 2026 0          
Balance at the end at Jun. 30, 2026 $ 0          
Beginning balance (in shares) at Dec. 31, 2025 2,203,620     2,203,620    
Beginning balance at Dec. 31, 2025 $ (98,837)     $ 0 5,893 (104,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares) 119,477          
Net loss $ (33,682)          
Comprehensive loss $ (33,682)          
Ending balance (in shares) at Jun. 30, 2026 33,446,315     33,446,315    
Ending balance at Jun. 30, 2026 $ 232,364     $ 0 370,776 (138,412)
Balance at the beginning (in shares) at Mar. 31, 2026 0          
Balance at the beginning at Mar. 31, 2026 $ 0          
Balance at the end (in shares) at Jun. 30, 2026 0          
Balance at the end at Jun. 30, 2026 $ 0          
Beginning balance (in shares) at Mar. 31, 2026       33,432,555    
Beginning balance at Mar. 31, 2026 250,112     $ 0 368,660 (118,548)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)       13,760    
Stock option exercises 31       31  
Stock-based compensation 2,085       2,085  
Net loss (19,864)         (19,864)
Comprehensive loss $ (19,864)         (19,864)
Ending balance (in shares) at Jun. 30, 2026 33,446,315     33,446,315    
Ending balance at Jun. 30, 2026 $ 232,364     $ 0 $ 370,776 $ (138,412)